NCT02225977View on ClinicalTrials.gov

Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.

CompletedOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

April 30, 2017

Conditions
Multiple Sclerosis
Interventions
DRUG

Gilenya

Trial Locations (1)

90033

University of Southern California, Department of Neurology, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT02225977 - Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya. | Biotech Hunter | Biotech Hunter